一种可注射的光热融合凝:实现温度可控制的温和光热疗法,以逆转化疗诱导的免疫耐受性
Meng Meng1,2, Jiayan Wu1,2, Xiaoya Guo1,2
1Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China.
Nano letters
|October 2, 2024
概括
这项研究开发了一种用于轻度光热疗法 (M-PTT) 和化疗的新型水凝 (FeTP@DLD/DLC). 该材料可以自我调节温度,并通过诱导免疫细胞死亡 (ICD) 来协同增强抗瘤效应.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 在瘤学瘤学.
背景情况:
- 轻度光热疗法 (M-PTT) 可以诱导免疫细胞死亡 (ICD),以克服化学疗法的免疫耐受性.
- 在M-PTT期间控制温度仍然是有效治疗癌症的挑战.
研究的目的:
- 为温度控制的M-PTT制定一个方便的策略.
- 为增强抗瘤效果创造一种协同化学-光热疗法.
主要方法:
- 构造的纳米粒子与劳里克酸 (LA),德费洛胺甲酸 (DFO) 和西斯 (CDDP).
- 将纳米颗粒纳入聚乙烯 (PVP) /酸 (TA) /Fe3+水凝中,形成FeTP@DLD/DLC.
- 利用LA的相变特性进行温度自调和,在达到43°C时释放DFO.
主要成果:
- FeTP@DLD/DLC通过释放DFO来破坏水凝并阻止温度在43°C时升高,证明了"光热融合效应".
- 获得了M-PTT诱导的ICD和CDDP化疗的协同效应.
- 通过单次给药,显示出强大的抗瘤功效.
结论:
- 开发的FeTP@DLD/DLC为温度控制的M-PTT提供了一个方便的解决方案.
- 这种方法有效地将化疗与M-PTT进行协同作用,以逆转免疫耐受性并增强抗瘤结果.
- 为振兴传统抗瘤疗法提供了一个有前途的战略.
更多相关视频
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
3.1K
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
2.3K
相关概念视频
Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
Decreased Body Temperature
602
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
602
